Conti, F, Magrini, L, Priori, R et al. · Allergy · 1996
This study measured a protein called eosinophil cationic protein (ECP) in the blood of ME/CFS patients to see if their immune cells called eosinophils were overly active. Researchers found that ME/CFS patients had significantly higher ECP levels than healthy controls, and most ME/CFS patients also tested positive for allergies. However, ME/CFS patients with allergies did not have higher ECP levels than those without allergies, suggesting the connection may be more complex than initially expected.
This was the first study documenting elevated eosinophil activation markers in ME/CFS, providing potential evidence of underlying immune system dysfunction. Understanding whether eosinophil activation contributes to ME/CFS pathophysiology could open new avenues for diagnosis and targeted treatment development.
This study does not prove that eosinophil activation causes ME/CFS symptoms or that allergies directly cause the immune activation seen. The cross-sectional design cannot establish temporal relationships or determine whether elevated ECP is a primary driver of disease or a secondary consequence of other disease mechanisms. Additionally, the high prevalence of allergy in CFS patients does not establish that allergy is necessary or sufficient for ME/CFS development.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →